Addition of rituximab in reduced intensity conditioning regimens for B-cell malignancies does not influence transplant outcomes: an EBMT registry analyses

M Jagasia; E Beohou; S van der Werf; D Niederwieser; P Dreger; E Meijer; P Chevallier; H Sengeloev; D Blaise; E Petersen; JJ Cornelissen; G Ehninger; J Gribben; D Caballero; Y Beguin; M Hallek; P Jindra; R Fanin; J Delage; J Maertens; T Gedde-Dahl; S Montoto; N Kroger; Hildegard Greinix; R Duarte

Addition of rituximab in reduced intensity conditioning regimens for B-cell malignancies does not influence transplant outcomes: an EBMT registry analyses

M Jagasia
, E Beohou
, S van der Werf
, D Niederwieser
, P Dreger
, E Meijer
, P Chevallier
, H Sengeloev
, D Blaise
, E Petersen
, JJ Cornelissen
, G Ehninger
, J Gribben
, D Caballero
, Y Beguin
, M Hallek
, P Jindra
, R Fanin
, J Delage
, J Maertens

T Gedde-Dahl, S Montoto, N Kroger, Hildegard Greinix, R Duarte

Division of Haematology

Research output: Contribution to journal › Conference abstract

Original language	English
Journal	Bone Marrow Transplantation
Publication status	Published - 2017
Event	43rd Annual Meeting of the European Group for Blood and Marrow Transplantation - Marseille, France Duration: 26 Mar 2017 → 29 Mar 2017

Branches of science

305 Other Human Medicine, Health Sciences
302 Clinical Medicine

Cite this

Jagasia, M., Beohou, E., van der Werf, S., Niederwieser, D., Dreger, P., Meijer, E., Chevallier, P., Sengeloev, H., Blaise, D., Petersen, E., Cornelissen, JJ., Ehninger, G., Gribben, J., Caballero, D., Beguin, Y., Hallek, M., Jindra, P., Fanin, R., Delage, J., ... Duarte, R. (2017). Addition of rituximab in reduced intensity conditioning regimens for B-cell malignancies does not influence transplant outcomes: an EBMT registry analyses. Bone Marrow Transplantation.

@article{94952cea3ffe4c908600103a277d9ef4,

title = "Addition of rituximab in reduced intensity conditioning regimens for B-cell malignancies does not influence transplant outcomes: an EBMT registry analyses",

author = "M Jagasia and E Beohou and \{van der Werf\}, S and D Niederwieser and P Dreger and E Meijer and P Chevallier and H Sengeloev and D Blaise and E Petersen and JJ Cornelissen and G Ehninger and J Gribben and D Caballero and Y Beguin and M Hallek and P Jindra and R Fanin and J Delage and J Maertens and T Gedde-Dahl and S Montoto and N Kroger and Hildegard Greinix and R Duarte",

year = "2017",

language = "English",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Springer Nature",

note = "43rd Annual Meeting of the European Group for Blood and Marrow Transplantation, EBMT 43 ; Conference date: 26-03-2017 Through 29-03-2017",

}

Jagasia, M, Beohou, E, van der Werf, S, Niederwieser, D, Dreger, P, Meijer, E, Chevallier, P, Sengeloev, H, Blaise, D, Petersen, E, Cornelissen, JJ, Ehninger, G, Gribben, J, Caballero, D, Beguin, Y, Hallek, M, Jindra, P, Fanin, R, Delage, J, Maertens, J, Gedde-Dahl, T, Montoto, S, Kroger, N, Greinix, H & Duarte, R 2017, 'Addition of rituximab in reduced intensity conditioning regimens for B-cell malignancies does not influence transplant outcomes: an EBMT registry analyses', Bone Marrow Transplantation.

TY - JOUR

T1 - Addition of rituximab in reduced intensity conditioning regimens for B-cell malignancies does not influence transplant outcomes: an EBMT registry analyses

AU - Jagasia, M

AU - Beohou, E

AU - van der Werf, S

AU - Niederwieser, D

AU - Dreger, P

AU - Meijer, E

AU - Chevallier, P

AU - Sengeloev, H

AU - Blaise, D

AU - Petersen, E

AU - Cornelissen, JJ

AU - Ehninger, G

AU - Gribben, J

AU - Caballero, D

AU - Beguin, Y

AU - Hallek, M

AU - Jindra, P

AU - Fanin, R

AU - Delage, J

AU - Maertens, J

AU - Gedde-Dahl, T

AU - Montoto, S

AU - Kroger, N

AU - Greinix, Hildegard

AU - Duarte, R

PY - 2017

Y1 - 2017

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000424355300102

M3 - Conference abstract

SN - 0268-3369

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

T2 - 43rd Annual Meeting of the European Group for Blood and Marrow Transplantation

Y2 - 26 March 2017 through 29 March 2017

ER -

Addition of rituximab in reduced intensity conditioning regimens for B-cell malignancies does not influence transplant outcomes: an EBMT registry analyses

Branches of science

Links

Cite this